1.
Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial
by Fayad, Zahi A, Prof
The Lancet (British edition), 2011, Vol.378 (9802), p.1547-1559

2.
Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes
by Zoungas, Sophia
Diabetologia, 2014-09-17, Vol.57 (12), p.2465-2474

3.

4.
Phosphodiesterase type-5 inhibitor use in type 2 diabetes is associated with a reduction in all-cause mortality
by Anderson, Simon G
Heart (British Cardiac Society), 2016-11, Vol.102 (21), p.1750-1756

5.
Glucosamine and chondroitin for knee osteoarthritis: a double-blind randomised placebo-controlled clinical trial evaluating single and combination regimens
by Fransen, Marlene
Annals of the rheumatic diseases, 2015-05, Vol.74 (5), p.851-858

6.
Rationale and design of dal-PLAQUE: A study assessing efficacy and safety of dalcetrapib on progression or regression of atherosclerosis using magnetic resonance imaging and 18F-fl...
by Fayad, Zahi A., PhD
The American heart journal, 2011, Vol.162 (2), p.214-221.e2

7.
Rapid Blood Pressure Lowering According to Recovery at Different Time Intervals after Acute Intracerebral Hemorrhage: Pooled Analysis of the INTERACT Studies
by Wang, Xia
Cerebrovascular diseases (Basel, Switzerland), 2015-04, Vol.39 (3-4), p.242-248

8.
Magnitude of blood pressure reduction and clinical outcomes in acute intracerebral hemorrhage: intensive blood pressure reduction in acute cerebral hemorrhage trial study
by Wang, Xia
Hypertension (Dallas, Tex. 1979), 2015-05, Vol.65 (5), p.1026-1032

9.
Predicting the effects of blood pressure-lowering treatment on major cardiovascular events for individual patients with type 2 diabetes mellitus results from action in diabetes and...
by Van Der Leeuw, Joep
Hypertension (Dallas, Tex. 1979), 2015-01-01, Vol.65 (1), p.115-121

10.
Lower Treatment Blood Pressure Is Associated With Greatest Reduction in Hematoma Growth After Acute Intracerebral Hemorrhage
by Arima, Hisatomi
Hypertension (Dallas, Tex. 1979), 2010-11, Vol.56 (5), p.852-858

11.
Symptom changes in five dimensions of the Positive and Negative Syndrome Scale in refractory psychosis
by Woodward, T.S
European archives of psychiatry and clinical neuroscience, 2014, Vol.264 (8), p.673-682

12.
A prospective, observational study of Xigris Use in the United States (XEUS)
by Steingrub, Jay S., MD
Journal of critical care, 2010, Vol.25 (4), p.660.e9-660.e16
